ISSN: 2633-5476
Human Immunodeficiency Virus can lead to the disease Acquired Immunodeficiency Syndrome, if untreated;this potentially life-threatening condition is common knowledge. However, despite being common, its nature or gravity is unknown to m...
Explore the journal aims, scope and subject coverage before submission.
View editorial leadership and board information for this journal.
Browse current research articles and article updates from this journal.
Open Access publishing information is available for authors and readers.
Dr. Yongxin Zhang, CEO of Zyxell Inc., was graduated from Beijing Medical University for both of his MD (1983) and PhD (1989), and received postdoctoral training in Baylor College of Medicine (1996-2004). He has the expertise in the research of immunology, including cancer immune therapy, infection immunology, transplantation immunology and Aging immunology. He worked on cancer vaccines, virus vaccines and bacteria vaccines for over 20 years. His research work on aging immunology revealed the mechanism of the compromised immune responses in aged subjects and exhibited the preventive effects of ex vivo reactivated and expanded lymphocytes on influenza virus infection in aged animals. He is also the inventor of ZYX Bioreactor, which has great advantages in expansion of immunocytes and hematopoietic stem cells over other systems.
Discover peer-reviewed open access journals across diverse disciplines.
